Format

Send to

Choose Destination
J Pharm Pract. 2019 Aug 7:897190019867601. doi: 10.1177/0897190019867601. [Epub ahead of print]

Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.

Author information

1
1 Department of Pharmacy, UC San Diego Health, San Diego, CA, USA.
2
2 Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Science, Buffalo, NY, USA.
3
3 Pharmacy Practice Department, Belmont University College of Pharmacy, Nashville, TN, USA.
4
4 Chicago College of Pharmacy, Midwestern University, Mt Sinai Medical Group, Downers Grove, IL, USA.
5
5 Department of Pediatrics & Neonatology, Wingate University School of Pharmacy, Novant Health Hemby Children's Hospital, Wingate, NC, USA.
6
6 University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX, USA.
7
7 Presbyterian College School of Pharmacy, Clinton, SC, USA.
8
8 Office of Research and Sponsored Programs, Midwestern University, Glendale, AZ, USA.
9
9 Department of Clinical and Administrative Pharmacy, Mercy Health Center, University of Georgia College of Pharmacy, Athens, GA, USA.
10
10 Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, USA.
11
11 College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
12
12 St Louis College of Pharmacy, SSM Health St. Mary's Clinical Pharmacy Specialist, St. Louis, MO, USA.

Abstract

INTRODUCTION:

Pharmacist prescribing of contraception is becoming increasingly available in selected states. The objective of this study was to assess US community pharmacists' perspectives on expanding access, barriers, and facilitators since states have begun pharmacist scope of practice expansions for prescribing contraception.

METHODS:

A survey study of US community pharmacists' support for expanded access models, pharmacist prescribing practices and interest, and importance of safety, cost, and professional practice issues for prescribing was conducted.

RESULTS:

Pharmacists are generally supportive of pharmacist prescribing and behind-the-counter models for hormonal contraception and generally opposed to over-the-counter access. A majority (65%) are interested in prescribing hormonal contraception. The top motivation for prescribing contraception is enjoying individual patient contact (94%). Safety concerns (eg, patients not obtaining health screenings) remained most important for pharmacist implementation, followed by cost (eg, lack of payment or reimbursement for pharmacists' services), and professional practice (eg, pharmacist time constraints and liability) issues.

CONCLUSION:

This study provides an updated understanding of attitudes toward models of expanded access to hormonal contraception, interest in prescribing, and barriers and facilitators to this service among community pharmacists. Many barriers such as time and reimbursement remain unchanged. This information can inform policy and implementation efforts.

KEYWORDS:

community pharmacy services; contraception; pharmacies; pharmacists; pharmacy legislation

PMID:
31390938
DOI:
10.1177/0897190019867601

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center